Next Generation Sequencing Kits Market to Grow at 8.34% through 2030F
The growing application in clinical diagnosis is expected
to drive the growth of Global Next Generation Sequencing Kits Market during the
forecast period, 2026-2030.
According to TechSci Research report, “Next Generation Sequencing Kits
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
2020-2030”, Global Next Generation Sequencing Kits Market was valued at USD 8.24 billion in 2024 and is expected to reach USD 13.22 billion by 2030 with a CAGR of 8.34%. This
can be ascribed to the growing prevalence of infectious diseases and genetic
disorders cases across the globe. The growing exponential rise in
next-generation sequencing demand for reducing the cost of genome sequencing is
also expected to boost the growth of the market during the forecast period.
Also, the growing research funding in the genome sciences is expected to
further enhance the demand for the NGS kits market during the forecast period.
Besides, the growing application of NGS kits in precision medicine and
molecular diagnostics is a major factor that is expected to drive the growth of
the market over the forecast period. Similarly, the growth in business and
corporate strategy is expected to create significant growth during the forecast
period. The increasing funding and favorable policies offered by the government
of different countries is expected to further boost the growth of the market
during the forecast period. Similarly, growing applications in clinical
diagnosis for early detection of diseases is expected to further boost the
growth of the market during the forecast period.
However, a lack of skilled
professionals for managing the NGS technology may slow down the growth of the
global Next Generation Sequencing Kits market in the forecast period. The legal
and ethical interpretation of complex data along with the high cost of reagents
can further restrict the growth of the global Next Generation Sequencing Kits
market. Similarly, the lack of infrastructure in emerging countries can further
restrict the growth of the Next Generation Sequencing Kits market during the
forecast period.
Next Generation Sequencing Kits market can be segmented on the basis of
workflow, sequencing type, application, end user, and region.
Based on the workflow, Sequencing Reagents Kits emerge as the Fastest Growing Segment. Sequencing reagents are critical for performing high-quality sequencing runs and ensuring accurate DNA or RNA amplification and detection. The widespread adoption of NGS in clinical diagnostics, personalized medicine, and research further drives the demand for sequencing reagents. As NGS technologies evolve, sequencing reagents kits are becoming more advanced, offering higher efficiency, reduced costs, and better performance across a range of sequencing platforms. These advancements contribute to the growing market share of sequencing reagents, particularly in oncology, rare genetic disease diagnostics, and infectious disease research, where precise sequencing is crucial. In contrast, while Library Preparation and Cluster Generation are vital steps, they rely heavily on the availability of reliable sequencing reagents, making sequencing kits the cornerstone of NGS applications.
Major companies operating in the Global Next Generation
Sequencing Kits market are:
- Agilent
Technologies, Inc.
- Bio-Rad
Laboratories, Inc.
- BGI
Group
- Creative
Biogene.
- Danaher
- F.
Hoffmann-La Roche Ltd
- Hologic,
Inc.
- Illumina,
Inc.
- Oxford
Nanopore Technologies plc.
- Pacific
Biosciences of California, Inc.
- PerkinElmer
Inc.
Customers can also request for 10% free customization
on this report.
“North America was expected to dominate the Global Next Generation Sequencing
Kits market owing to the growing number of major market players along with
growing adoption of NGS in research, diagnostic labs, and synthetic biology
research across the region. Similarly, the growing prevalence of infectious
diseases, genetic disorders, and chronic diseases such as cancer and the
development of novel library preparation kits for early detection of diseases
is expected to create significant growth during the forecast period. The
growing applications in drug discovery and replacing old technology such as
microarrays will further drive market growth over the years. A growing number
of clinical trials for developing novel vaccines with whole genome sequencing
is required which will further drive the growth of the market. Besides, the
growing adoption of advanced NGS technology by government and non-government
bodies are further expected to create lucrative opportunities for market
growth,” said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based global management consulting firm.
“Next Generation Sequencing Kits Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By
Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits),
By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing,
Other Sequencing), By Usage Area (Clinical, Research), By Application
(Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others), By
End User (Academic and Research Institutions, Pharmaceutical and Biotechnology
Companies, Clinical and Diagnostic Laboratories, Others) By Region
& Competition 2020-2030F”, has evaluated the future growth
potential of global Next Generation Sequencing Kits market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision-makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in the Global Next Generation Sequencing Kits
market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com